Insecticides (India) Limited schedules Q1 FY27 earnings call for August 11, 2026
Insecticides (India) Limited will announce its Q1 FY27 financial results on August 11, 2026. The company will host an Earning Conference Call on the same day at 5:00 PM IST to discuss the results. Key management personnel will participate.
The announcement provides important information for investors and analysts regarding the upcoming financial results and the opportunity to discuss them. This is a key event for stakeholders to understand the company's performance and outlook.
The announcement is a routine intimation of an upcoming earnings conference call and financial results release. It does not contain any new financial data or specific performance indicators that would suggest a positive or negative sentiment.
Insecticides (India) Limited has announced its upcoming Earning Conference Call, scheduled for Tuesday, August 11, 2026, from 05:00 PM IST. The call will focus on discussing the company's financial results for the first quarter of the fiscal year 2027 (Q1 FY27).
The Standalone & Consolidated Unaudited Financial results for the quarter ended June 30, 2026, will be announced on the same day, August 11, 2026.
Representing Insecticides (India) Limited on the conference call will be Mr. Rajesh Kumar Aggarwal, Managing Director; Mr. Sandeep Kumar Aggarwal, CFO; Mr. Devendra Kumar Ray, Chief Operating Officer; and Mr. Dushyant Sood, Chief Marketing Officer.
Details for the conference call include: Time: 05:00 PM IST on Tuesday, August 11, 2026 India Access Numbers: +91 22 6280 1550 / +91 22 7115 8378 International Access Numbers are available for Hong Kong, Singapore, USA, and UK.
Participants are encouraged to pre-register for the call. For further information regarding the conference call, attendees can contact Mr. Nikunj Seth or Ms. Sejal Bhattar.
What to do with a filing like this
Insecticides (India) Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Insecticides (India) Limited. Read the original for the full detail.